Twist Bioscience (TWST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ROBERT CHESS, a director at $TWST ($TWST), sold 709 shares of the company on 12-05-2024. We received data on the trade from a recent SEC filing. This was a sale of ...

Beginning January 2025, the Buff Pantry will use PantrySoft for all appointments and student messaging. CUServes will no longer list Buff Pantry appointments. The Buff Pantry, CU Boulder's on-campus ...

Roche Holding AG Akt 1.12% CHF206.11B ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

View Twist Bioscience Corporation (TWST) current and estimated P/E ratio data provided by Seeking Alpha.

Latest build status with azerothcore: ...

Investors in Twist Bioscience Corp (Symbol: TWST) saw new options become available this week, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...